NTRK2 and schizophrenia: Fang et al. (2017) report that supplementation with n−3 PUFA could prevent neuronal loss and cognitive impairment via enhancement of the cAMP-response element-binding protein (CREB)/BDNF/tyrosine kinase B (TrkB) pathway in an animal model of schizophrenia.